Copyright
©The Author(s) 2025.
World J Gastrointest Endosc. Feb 16, 2025; 17(2): 102532
Published online Feb 16, 2025. doi: 10.4253/wjge.v17.i2.102532
Published online Feb 16, 2025. doi: 10.4253/wjge.v17.i2.102532
Table 5 Outcome of patients treated with endoscopy urgently vs non-urgently, mean ± SD or n (%)
Endoscopy < 24 hours, n = 19 | Endoscopy > 24 hours, n = 19 | P value | |
Mortality at 30 days | 6 (31.6) | 2 (10.5) | 0.11 |
Mortality at 1 year | 4 (21.1) | 6 (31.6) | 0.46 |
ICU admission | 9 (47) | 5 (26.3) | 0.18 |
PRBC transfusion | 17 (89.5) | 17 (89.5) | 1.0 |
PLT transfusion | 19 (100) | 18 (94.7) | 0.31 |
Recurrent bleeding | 3 (15.8) | 11 (57.9) | 0.01a |
Length of stay (days) | 13.5 ± 13 | 22.1± 33.9 | 0.31 |
- Citation: Alhumayyd B, Naumann A, Cashen A, Chen CH. Clinical impact of endoscopy in severely thrombocytopenic patients with hematologic malignancy experiencing gastrointestinal bleeding. World J Gastrointest Endosc 2025; 17(2): 102532
- URL: https://www.wjgnet.com/1948-5190/full/v17/i2/102532.htm
- DOI: https://dx.doi.org/10.4253/wjge.v17.i2.102532